DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, “Money Ball – Winning Venture Strategies.”
News | 03. 19. 2013
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, “Money Ball – Winning Venture Strategies.”
